A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 Monotherapy in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation

by | Aug 25, 2026 | Clinical Trials

​ Conditions: Pancreatic Cancer Interventions: Drug: GFH375; Drug: GFH276; Drug: GFS202A Sponsors: Genfleet Therapeutics (Shanghai) Inc. Not yet recruiting Conditions: Pancreatic Cancer Interventions: Drug: GFH375; Drug: GFH276; Drug: GFS202A Sponsors: Genfleet...

Effectiveness of Combining Patient Follow-Up With an Educational Intervention on Self-Management Skills of Type 2 Diabetes Mellitus Patients: A Controlled Intervention Study in Primary Care

by | Aug 24, 2026 | Clinical Trials

​ Conditions: Diabetes Mellitus Type 2 Interventions: Behavioral: A structured shared follow-up plan combined with patient education Sponsors: Aysenur Aktemur Completed Conditions: Diabetes Mellitus Type 2 Interventions: Behavioral: A structured shared follow-up plan...